Sort
38,696 grants matching “als”
Acquisition of a Magnetic Resonance Imaging (MRI) System for Cognitive Neuroscience
$929,890Helen J Neville · University Of Oregon Eugene · · FY2000 · SBE
The Neural Basis of Functional MRI Responses
$929,620David A Leopold · National Institute Of Mental Health · ZIA · FY2019 · MH
La Jolla Interdisciplinary Neuroscience Center Cores
$929,553Stuart A Lipton · Sanford Burnham Prebys Medical Discovery Institute · P30 · FY2011 · NS
BEYOND CUATSM: NOVEL COPPER COMPLEXES FOR IMPROVED ALS THERAPY
$928,649University Of Louisville · · FY2025 · Defense Health Agency
Dynamics and Genetics of HIV Proviruses before and during Antiretroviral Therapy
$928,476Mary Kearney · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
A New Target for Chromatin Remodeler Defects in Cancer
$928,212Cheryl L Walker · Baylor College Of Medicine · R35 · FY2022 · CA
5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder
$927,912Matthew Wayne Johnson · Johns Hopkins University · U01 · FY2024 · DA
A systems approach to manipulate microbial adaptation to structured environments
$927,560Nitin S Baliga · Institute For Systems Biology · R01 · FY2019 · AI
EAGeR Trial - The Effects of Aspirin in Gestation and Reproduction Trial
$927,320Enrique Schisterman · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2018 · HD
Interaction of Genotype and Level of Dietary Restriction on Lifespan and Aging
$927,220Arlan G. Richardson · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2017 · AG
Interaction of Genotype and Level of Dietary Restriction on Lifespan and Aging
$927,220Arlan G. Richardson · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2016 · AG
NEWBORN SCREENING PILOT STUDY FOR EXPANDED GROUP OF HOMOCYSTINURIA (HCU)-RELATED DISORDERS (TERNED "EXPANDED HCU")
$926,734William Wilcox · Emory University · N01 · FY2020 · HD
Novel Therapy for Amyotrophic Lateral Sclerosis
$926,669David E Smith · Angion Biomedica Corporation · R44 · FY2010 · NS
Anti-Aging Mitochondrial Protein Therapy for Alzheimer?s Disease and Sarcopenia
$926,657James Pepper Bennett · Gencia Corporation · R42 · FY2009 · AG
SELECTIVE REDUCTION OF REPEAT EXPANSION RNA WITH SMALL MOLECULES TO TREAT C9ORF72 MEDIATED ALS
$925,757Wake Forest University Health Sciences · · FY2025 · Defense Health Agency
Cell Adhesion and Trafficking as a Therapeutic Target in Allotransplantation
$925,328Allan D. Kirk · Emory University · U19 · FY2014 · AI
Regulation and functional effects of localized RNAs
$924,606Stavroula Mili · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Culturally-responsive teaching for supporting positive computer science identities among Latinx girls
$924,479Ma Bernadette A Salgarino · Santa Clara County Office Of Education · · FY2021 · EDU
HIV-1 Genetic Variation in Infected Individuals
$924,183Frank Maldarelli · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Uncovering the neural circuit and synaptic mechanisms underlying interval timing
$924,000James Gerard Heys · University Of Utah · DP2 · FY2024 · MH
Signal Transduction Events and the Regulation of Cell Growth
$923,994Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2019 · CA
TDP-43 aggregation inhibitors for the treatment of ALS
$923,960Glenn Larsen · Aquinnah Pharmaceuticals, Inc. · R44 · FY2018 · NS
Functional and mechanistic studies of human-specific long noncoding RNAs using a humanized mouse model
$923,639Haiming Cao · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
Molecular Basis of Obesity and Obesity-induced Metabolic Diseases
$923,639Haiming Cao · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
Clinical Research in ALS & Related Disorders for Therapeutic Development (CReATe) - Project Core #1
$922,756Michael Benatar · University Of Miami School Of Medicine · U54 · FY2022 · NS